Cargando…

Cardiac damage after treatment of childhood cancer: A long-term follow-up

BACKGROUND: With improved childhood cancer cure rate, long term sequelae are becoming an important factor of quality of life. Signs of cardiovascular disease are frequently found in long term survivors of cancer. Cardiac damage may be related to irradiation and chemotherapy. We have evaluated simult...

Descripción completa

Detalles Bibliográficos
Autores principales: Velensek, Veronika, Mazic, Uros, Krzisnik, Ciril, Demšar, Damjan, Jazbec, Janez, Jereb, Berta
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2430718/
https://www.ncbi.nlm.nih.gov/pubmed/18492236
http://dx.doi.org/10.1186/1471-2407-8-141
_version_ 1782156425246539776
author Velensek, Veronika
Mazic, Uros
Krzisnik, Ciril
Demšar, Damjan
Jazbec, Janez
Jereb, Berta
author_facet Velensek, Veronika
Mazic, Uros
Krzisnik, Ciril
Demšar, Damjan
Jazbec, Janez
Jereb, Berta
author_sort Velensek, Veronika
collection PubMed
description BACKGROUND: With improved childhood cancer cure rate, long term sequelae are becoming an important factor of quality of life. Signs of cardiovascular disease are frequently found in long term survivors of cancer. Cardiac damage may be related to irradiation and chemotherapy. We have evaluated simultaneous influence of a series of independent variables on the late cardiac damage in childhood cancer survivors in Slovenia and identified groups at the highest risk. METHODS: 211 long-term survivors of different childhood cancers, at least five years after treatment were included in the study. The evaluation included history, physical examination, electrocardiograpy, exercise testing and echocardiograpy. For analysis of risk factors, beside univariate analysis, multivariate classification tree analysis statistical method was used. RESULTS AND CONCLUSION: Patients treated latest, from 1989–98 are at highest risk for any injury to the heart (73%). Among those treated earlier are at the highest risk those with Hodgkin's disease treated with irradiation above 30 Gy and those treated for sarcoma. Among specific forms of injury, patients treated with radiation to the heart area are at highest risk of injury to the valves. Patients treated with large doses of anthracyclines or concomitantly with anthracyclines and alkylating agents are at highest risk of systolic function defect and enlarged heart chambers. Those treated with anthracyclines are at highest risk of diastolic function defect. The time period of the patient's treatment is emerged as an important risk factor for injury of the heart.
format Text
id pubmed-2430718
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-24307182008-06-19 Cardiac damage after treatment of childhood cancer: A long-term follow-up Velensek, Veronika Mazic, Uros Krzisnik, Ciril Demšar, Damjan Jazbec, Janez Jereb, Berta BMC Cancer Research Article BACKGROUND: With improved childhood cancer cure rate, long term sequelae are becoming an important factor of quality of life. Signs of cardiovascular disease are frequently found in long term survivors of cancer. Cardiac damage may be related to irradiation and chemotherapy. We have evaluated simultaneous influence of a series of independent variables on the late cardiac damage in childhood cancer survivors in Slovenia and identified groups at the highest risk. METHODS: 211 long-term survivors of different childhood cancers, at least five years after treatment were included in the study. The evaluation included history, physical examination, electrocardiograpy, exercise testing and echocardiograpy. For analysis of risk factors, beside univariate analysis, multivariate classification tree analysis statistical method was used. RESULTS AND CONCLUSION: Patients treated latest, from 1989–98 are at highest risk for any injury to the heart (73%). Among those treated earlier are at the highest risk those with Hodgkin's disease treated with irradiation above 30 Gy and those treated for sarcoma. Among specific forms of injury, patients treated with radiation to the heart area are at highest risk of injury to the valves. Patients treated with large doses of anthracyclines or concomitantly with anthracyclines and alkylating agents are at highest risk of systolic function defect and enlarged heart chambers. Those treated with anthracyclines are at highest risk of diastolic function defect. The time period of the patient's treatment is emerged as an important risk factor for injury of the heart. BioMed Central 2008-05-20 /pmc/articles/PMC2430718/ /pubmed/18492236 http://dx.doi.org/10.1186/1471-2407-8-141 Text en Copyright © 2008 Velensek et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Velensek, Veronika
Mazic, Uros
Krzisnik, Ciril
Demšar, Damjan
Jazbec, Janez
Jereb, Berta
Cardiac damage after treatment of childhood cancer: A long-term follow-up
title Cardiac damage after treatment of childhood cancer: A long-term follow-up
title_full Cardiac damage after treatment of childhood cancer: A long-term follow-up
title_fullStr Cardiac damage after treatment of childhood cancer: A long-term follow-up
title_full_unstemmed Cardiac damage after treatment of childhood cancer: A long-term follow-up
title_short Cardiac damage after treatment of childhood cancer: A long-term follow-up
title_sort cardiac damage after treatment of childhood cancer: a long-term follow-up
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2430718/
https://www.ncbi.nlm.nih.gov/pubmed/18492236
http://dx.doi.org/10.1186/1471-2407-8-141
work_keys_str_mv AT velensekveronika cardiacdamageaftertreatmentofchildhoodcanceralongtermfollowup
AT mazicuros cardiacdamageaftertreatmentofchildhoodcanceralongtermfollowup
AT krzisnikciril cardiacdamageaftertreatmentofchildhoodcanceralongtermfollowup
AT demsardamjan cardiacdamageaftertreatmentofchildhoodcanceralongtermfollowup
AT jazbecjanez cardiacdamageaftertreatmentofchildhoodcanceralongtermfollowup
AT jerebberta cardiacdamageaftertreatmentofchildhoodcanceralongtermfollowup